The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Analysis of OX40 agonist antibody (PF-04518600) in patients with hepatocellular carcinoma.
 
Anthony B. El-Khoueiry
Honoraria - Agenus; Agenus; Agenus; Agenus; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; CytomX Therapeutics; CytomX Therapeutics; CytomX Therapeutics; CytomX Therapeutics; CytomX Therapeutics; CytomX Therapeutics; CytomX Therapeutics; CytomX Therapeutics; Eisai; Eisai; Eisai; Eisai; EMD Serono; EMD Serono; EMD Serono; EMD Serono; Exelixis; Exelixis; Exelixis; Exelixis; Merck; Merck; Merck; Merck; Pieris Pharmaceuticals; Pieris Pharmaceuticals; Pieris Pharmaceuticals; Pieris Pharmaceuticals; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech
Consulting or Advisory Role - Agenus; Agenus; Agenus; Agenus; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; CytomX Therapeutics; CytomX Therapeutics; CytomX Therapeutics; CytomX Therapeutics; Eisai; Eisai; Eisai; Eisai; EMD Serono; EMD Serono; EMD Serono; EMD Serono; Exelixis; Exelixis; Exelixis; Exelixis; Merck; Merck; Merck; Merck; Pieris Pharmaceuticals; Pieris Pharmaceuticals; Pieris Pharmaceuticals; Pieris Pharmaceuticals; Roche; Roche; Roche; Roche
Research Funding - Astex Pharmaceuticals; Astex Pharmaceuticals; Astex Pharmaceuticals; Astex Pharmaceuticals; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Merck; Merck; Merck; Merck
 
Jean-Philippe Spano
Honoraria - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Biogaran Pharmaceuticals; Biogaran Pharmaceuticals; Biogaran Pharmaceuticals; Biogaran Pharmaceuticals; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Gilead Sciences; Gilead Sciences; Gilead Sciences; Gilead Sciences; Leo Pharma; Leo Pharma; Leo Pharma; Leo Pharma; Lilly; Lilly; Lilly; Lilly; Myriad Pharmaceuticals; Myriad Pharmaceuticals; Myriad Pharmaceuticals; Myriad Pharmaceuticals; Pfizer; Pfizer; Pfizer; Pfizer
Consulting or Advisory Role - MSD; MSD; MSD; MSD; Roche; Roche; Roche; Roche
 
ERIC ANGEVIN
Consulting or Advisory Role - Celgene; Celgene; Celgene; Celgene; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; MedImmune; MedImmune; MedImmune; MedImmune; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme
Research Funding - Abbvie; Abbvie; Abbvie; Abbvie; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; MedImmune; MedImmune; MedImmune; MedImmune; Octimet; Octimet; Octimet; Octimet; Pfizer; Pfizer; Pfizer; Pfizer; Sanofi; Sanofi; Sanofi; Sanofi
Travel, Accommodations, Expenses - Abbvie; Abbvie; Abbvie; Abbvie; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Innate Pharma; Innate Pharma; Innate Pharma; Innate Pharma
 
Toshihiko Doi
Honoraria - Abbvie; Abbvie; Abbvie; Abbvie; Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Bristol-Myers Squibb Japan; Bristol-Myers Squibb Japan; Bristol-Myers Squibb Japan; Bristol-Myers Squibb Japan; Oncolys BioPharma; Oncolys BioPharma; Oncolys BioPharma; Oncolys BioPharma; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Abbvie; Abbvie; Abbvie; Abbvie; Amgen; Amgen; Amgen; Amgen; Bayer; Bayer; Bayer; Bayer; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; MSD; MSD; MSD; MSD; Novartis; Novartis; Novartis; Novartis; Rakuten Medical; Rakuten Medical; Rakuten Medical; Rakuten Medical; Sumitomo Dainippon; Sumitomo Dainippon; Sumitomo Dainippon; Sumitomo Dainippon; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Takeda; Takeda; Takeda; Takeda
Research Funding - Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Kyowa Hakko Kirin (Inst); Kyowa Hakko Kirin (Inst); Kyowa Hakko Kirin (Inst); Kyowa Hakko Kirin (Inst); Lilly Japan (Inst); Lilly Japan (Inst); Lilly Japan (Inst); Lilly Japan (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); MSD (Inst); MSD (Inst); MSD (Inst); MSD (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Quintiles (Inst); Quintiles (Inst); Quintiles (Inst); Quintiles (Inst); Sumitomo Group (Inst); Sumitomo Group (Inst); Sumitomo Group (Inst); Sumitomo Group (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Andrea J. Bullock
Stock and Other Ownership Interests - Amgen; Amgen; Amgen; Amgen; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson; Medtronic; Medtronic; Medtronic; Medtronic
Consulting or Advisory Role - Eisai; Eisai; Eisai; Eisai; Exelixis; Exelixis; Exelixis; Exelixis; Halozyme; Halozyme; Halozyme; Halozyme
 
William Proctor Harris
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Eisai; Eisai; Eisai; Exelixis; Exelixis; Exelixis; Exelixis; Neo Therma; Neo Therma; Neo Therma; Neo Therma
Research Funding - Agios (Inst); Agios (Inst); Agios (Inst); Agios (Inst); ArQule (Inst); ArQule (Inst); ArQule (Inst); ArQule (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); BTG (Inst); BTG (Inst); BTG (Inst); BTG (Inst); Exelixis (Inst); Exelixis (Inst); Exelixis (Inst); Exelixis (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Eisai; Eisai; Eisai; Eisai
 
Omid Hamid
Honoraria - Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Novartis; Novartis; Novartis; Novartis; Sanofi/Regeneron; Sanofi/Regeneron; Sanofi/Regeneron; Sanofi/Regeneron
Consulting or Advisory Role - Aduro Biotech; Aduro Biotech; Aduro Biotech; Aduro Biotech; Akeso Biopharma; Akeso Biopharma; Akeso Biopharma; Akeso Biopharma; Amgen; Amgen; Amgen; Amgen; Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma; BeiGene; BeiGene; BeiGene; BeiGene; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Genentech; Genentech; Genentech; Genentech; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Immunocore; Immunocore; Immunocore; Immunocore; Incyte; Incyte; Incyte; Incyte; Janssen; Janssen; Janssen; Janssen; Merck; Merck; Merck; Merck; NextCure; NextCure; NextCure; NextCure; Novartis; Novartis; Novartis; Novartis; Regeneron; Regeneron; Regeneron; Regeneron; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi; Seagen; Seagen; Seagen; Seagen; Tempus; Tempus; Tempus; Tempus; Zelluna; Zelluna; Zelluna; Zelluna
Speakers' Bureau - Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Novartis; Novartis; Novartis; Novartis; Sanofi/Regeneron; Sanofi/Regeneron; Sanofi/Regeneron; Sanofi/Regeneron
Research Funding - Aduro Biotech (Inst); Aduro Biotech (Inst); Aduro Biotech (Inst); Aduro Biotech (Inst); Akeso Biopharma (Inst); Akeso Biopharma (Inst); Akeso Biopharma (Inst); Akeso Biopharma (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Arcus Biosciences (Inst); Arcus Biosciences (Inst); Arcus Biosciences (Inst); Arcus Biosciences (Inst); Array BioPharma (Inst); Array BioPharma (Inst); Array BioPharma (Inst); Array BioPharma (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); CytomX Therapeutics (Inst); CytomX Therapeutics (Inst); CytomX Therapeutics (Inst); CytomX Therapeutics (Inst); Exelixis (Inst); Exelixis (Inst); Exelixis (Inst); Exelixis (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); Immunocore (Inst); Immunocore (Inst); Immunocore (Inst); Immunocore (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Iovance Biotherapeutics (Inst); Iovance Biotherapeutics (Inst); Iovance Biotherapeutics (Inst); Iovance Biotherapeutics (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); Moderna Therapeutics (Inst); Moderna Therapeutics (Inst); Moderna Therapeutics (Inst); Moderna Therapeutics (Inst); NextCure (Inst); NextCure (Inst); NextCure (Inst); NextCure (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Regeneron (Inst); Regeneron (Inst); Regeneron (Inst); Regeneron (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Torque (Inst); Torque (Inst); Torque (Inst); Torque (Inst); Zelluna (Inst); Zelluna (Inst); Zelluna (Inst); Zelluna (Inst)
 
Paul Gougis
No Relationships to Disclose
 
Alison Forgie
Employment - Pfizer; Pfizer; Pfizer; Pfizer
Stock and Other Ownership Interests - Pfizer; Pfizer; Pfizer; Pfizer
Patents, Royalties, Other Intellectual Property - Pfizer; Pfizer; Pfizer; Pfizer
Travel, Accommodations, Expenses - Pfizer; Pfizer; Pfizer; Pfizer
 
Wenjing Yang
Employment - Pfizer; Pfizer; Pfizer; Pfizer
Stock and Other Ownership Interests - Pfizer; Pfizer; Pfizer; Pfizer
Travel, Accommodations, Expenses - Pfizer; Pfizer; Pfizer; Pfizer
 
Ken Liao
Employment - Pfizer; Pfizer; Pfizer; Pfizer
Stock and Other Ownership Interests - Pfizer; Pfizer; Pfizer; Pfizer
Travel, Accommodations, Expenses - Pfizer; Pfizer; Pfizer; Pfizer
 
Ruifeng Li
Employment - Pfizer; Pfizer; Pfizer; Pfizer
Stock and Other Ownership Interests - Pfizer; Pfizer; Pfizer; Pfizer
Travel, Accommodations, Expenses - Pfizer; Pfizer; Pfizer; Pfizer
 
Carrie T. Taylor
Employment - Pfizer; Pfizer; Pfizer; Pfizer
Stock and Other Ownership Interests - Pfizer; Pfizer; Pfizer; Pfizer
Travel, Accommodations, Expenses - Pfizer; Pfizer; Pfizer; Pfizer
 
Jeffrey Chou
Employment - Pfizer; Pfizer; Pfizer; Pfizer
Stock and Other Ownership Interests - Pfizer; Pfizer; Pfizer; Pfizer
Research Funding - Pfizer; Pfizer; Pfizer; Pfizer
Travel, Accommodations, Expenses - Pfizer; Pfizer; Pfizer; Pfizer
 
Ferry Eskens
Consulting or Advisory Role - Eisai; Eisai; Eisai; Eisai; Ipsen; Ipsen; Ipsen; Ipsen; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Roche; Roche; Roche; Roche
Travel, Accommodations, Expenses - Pfizer; Pfizer; Pfizer; Pfizer